Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Wiley
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/96b6a2e1ce744fbab61316cd9a77ffd1 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| id |
oai:doaj.org-article:96b6a2e1ce744fbab61316cd9a77ffd1 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:96b6a2e1ce744fbab61316cd9a77ffd12021-11-30T07:25:38ZIdentification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy2001-132610.1002/ctm2.598https://doaj.org/article/96b6a2e1ce744fbab61316cd9a77ffd12021-11-01T00:00:00Zhttps://doi.org/10.1002/ctm2.598https://doaj.org/toc/2001-1326Junyu LongXu YangJin BianDongxu WangAnqiang WangYu LinMingjun ZhengHaohai ZhangXinting SangHaitao ZhaoWileyarticleMedicine (General)R5-920ENClinical and Translational Medicine, Vol 11, Iss 11, Pp n/a-n/a (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Junyu Long Xu Yang Jin Bian Dongxu Wang Anqiang Wang Yu Lin Mingjun Zheng Haohai Zhang Xinting Sang Haitao Zhao Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy |
| format |
article |
| author |
Junyu Long Xu Yang Jin Bian Dongxu Wang Anqiang Wang Yu Lin Mingjun Zheng Haohai Zhang Xinting Sang Haitao Zhao |
| author_facet |
Junyu Long Xu Yang Jin Bian Dongxu Wang Anqiang Wang Yu Lin Mingjun Zheng Haohai Zhang Xinting Sang Haitao Zhao |
| author_sort |
Junyu Long |
| title |
Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy |
| title_short |
Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy |
| title_full |
Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy |
| title_fullStr |
Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy |
| title_full_unstemmed |
Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy |
| title_sort |
identification of tmb, cd8 t‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐pd‐1/pd‐l1 therapy |
| publisher |
Wiley |
| publishDate |
2021 |
| url |
https://doaj.org/article/96b6a2e1ce744fbab61316cd9a77ffd1 |
| work_keys_str_mv |
AT junyulong identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT xuyang identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT jinbian identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT dongxuwang identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT anqiangwang identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT yulin identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT mingjunzheng identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT haohaizhang identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT xintingsang identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT haitaozhao identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy |
| _version_ |
1718406764545703936 |